On Monday, Lexeo Therapeutics Inc (NASDAQ: LXEO) was 4.87% up from the session before settling in for the closing price of $9.04. A 52-week range for LXEO has been $1.45 – $10.38.
Healthcare Sector giant saw their annual sales slid by -99.98% over the last five years. When this article was written, the company’s average yearly earnings per share was at 36.65%. With a float of $61.25 million, this company’s outstanding shares have now reached $72.99 million.
Lexeo Therapeutics Inc (LXEO) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Lexeo Therapeutics Inc stocks. The insider ownership of Lexeo Therapeutics Inc is 16.08%, while institutional ownership is 70.61%. The most recent insider transaction that took place on Oct 17 ’25, was worth 34,767. In this transaction Chief Development Officer of this company sold 3,888 shares at a rate of $8.94, taking the stock ownership to the 65,862 shares. Before that another transaction happened on Oct 17 ’25, when Company’s Chief Legal Officer sold 3,526 for $8.94, making the entire transaction worth $31,530. This insider now owns 68,930 shares in total.
Lexeo Therapeutics Inc (LXEO) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.78 earnings per share (EPS) during the time that was better than consensus figure (set at -0.78) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.44 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 36.65% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 19.65% during the next five years compared to -99.98% drop over the previous five years of trading.
Lexeo Therapeutics Inc (NASDAQ: LXEO) Trading Performance Indicators
You can see what Lexeo Therapeutics Inc (LXEO) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 7.40.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.70, a number that is poised to hit -0.32 in the next quarter and is forecasted to reach -1.59 in one year’s time.
Technical Analysis of Lexeo Therapeutics Inc (LXEO)
Analysing the last 5-days average volume posted by the [Lexeo Therapeutics Inc, LXEO], we can find that recorded value of 0.92 million was better than the volume posted last year of 0.78 million. As of the previous 9 days, the stock’s Stochastic %D was 76.65%.
During the past 100 days, Lexeo Therapeutics Inc’s (LXEO) raw stochastic average was set at 86.73%, which indicates a significant increase from 66.91% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.64 in the past 14 days, which was higher than the 0.46 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.73, while its 200-day Moving Average is $4.78. Now, the first resistance to watch is $9.79. This is followed by the second major resistance level at $10.11. The third major resistance level sits at $10.59. If the price goes on to break the first support level at $8.99, it is likely to go to the next support level at $8.51. Should the price break the second support level, the third support level stands at $8.19.
Lexeo Therapeutics Inc (NASDAQ: LXEO) Key Stats
There are 72,987K outstanding shares of the company, which has a market capitalization of 691.92 million. As of now, sales total 0 K while income totals -98,330 K. Its latest quarter income was 0 K while its last quarter net income were -20,280 K.
